Author:
Smith Matthew R,Saad Fred,Coleman Robert,Shore Neal,Fizazi Karim,Tombal Bertrand,Miller Kurt,Sieber Paul,Karsh Lawrence,Damião Ronaldo,Tammela Teuvo L,Egerdie Blair,Van Poppel Hendrik,Chin Joseph,Morote Juan,Gómez-Veiga Francisco,Borkowski Tomasz,Ye Zhishen,Kupic Amy,Dansey Roger,Goessl Carsten
Reference30 articles.
1. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007);Norgaard;J Urol,2010
2. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999–2006;Sathiakumar;Prostate Cancer Prostat Dis,2011
3. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001
4. NCCN task force report: bone health in cancer care;Gralow;J Natl Compr Canc Netw,2009
5. Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer;Nelson;Cancer,2008
Cited by
672 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献